Signaling intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK pathways) as therapeutic targets for anti-cancer and anti-angiogenesis treatments

Ludovica Ciuffreda, James A. McCubrey, Michele Milella

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Signaling intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK pathways) as therapeutic targets for anti-cancer and anti-angiogenesis treatments'. Together they form a unique fingerprint.

Medicine & Life Sciences